She blames US monetary policy for distorting the current market. The Fed Reserve has been too eager to print money for the last 20 years while the treasury has been too willing to spend big on stimulus. It's no longer true that the dollar moves in the opposite direction of risk assets and most commodities. Patterns: when Trump was first and sworn in, the dollar fell 15%; it also fell the next time he was sworn in, but later bounced when US companies repatriate their cash. Oil: In March when the dollar bottomed, oil soared. Any oil rally will cap at $80-85 for WTI, or $105 if the US-Iran war resumes. If prices keep falling, it will reach a floor of $57. Gold: When gold bottomed in mid-2022, the USD was peaking. In early 2026, it was the reverse. When gold sells off, it sells off hard, now down $1,500 from highs. Any relief rally won't last and gold will continue to fall.
Is the only non-tech stock in the top 15 of the S&P, up 146% this year. Last Thursday at their science event, the company talked about emerging drugs in clinical trials, including entirely new categories of medicine. Oncology drugs are in late trials to treat melanoma, and forms of lung and bladder cancer. This excited investors. However, they're still losing money while EPS likely won't turn positive until 2029. That said, they're still working on personalized anti-cancer vaccines which will take longer. Shares have had a great run, but wait for a pullback.
Bloomberg reported that Meta is planning a cloud business to sell AI computing. Shares jumped 11% or $50. He had predicted $100 eventually, and shares have more room to run. Their enterprise cloud will be instantly profitable. The company is too focused on consumers and ads.